| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5725338 | Revue des Maladies Respiratoires Actualités | 2016 | 12 Pages |
Abstract
France is widely involved in the assessment of these different new treatments and strategies by prospective multicentric clinical trials (IFCT MAPS-2 trialâ¦), helped by the national clinical network of expert centers for MPM, “MESOCLIN”, in connection with patients'associations.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
A. Scherpereel,